-
ICPerMed Virtual Conference Personalised Medicine – From Vision to Practice February 25-26, 2021
26 February 2021 – The second conference of ICPerMed “Personalised Medicine – From Vision to Practice” assembled virtually around 500 viewers from 57 countries. The conference was hosted by the French National Research Agency (ANR) on February 25-26, 2021 and presented solutions and strategies on how to successfully implement personalised medicine approaches.
-
Announcement of the Open Market Consultation of the EU – Innovation Procurement project Instand-NGS4P
26 February 2021 – An Open Market Consultation of the H2020 Pre-Commercial Procurement of Instand-NGS4P will be held on 22-23 March 2021 regarding integrated and standardized Next Generation Sequencing workflows for personalised therapy.
-
ICPerMed Virtual Conference 2021 is now started! Promotion of solutions, strategies and best practices needed for the implementation of personalised medicine
25 February 2021 – What are the challenges and the existing solutions for Personalised Medicine implementation? This key question is at the heart of the virtual conference organised on February 25-26, 2021. The event assembles around 600 participants from 57 different countries.
-
SAPHIRe survey on Organisation of Personalised Health
24 February 2021 – This survey is set up give a comprehensive overview of the organisation of the competences related to Personalised Medicine at the different levels in the different Regions/Countries of Europe.
-
Draft Concept Paper “European Partnership for Personalised Medicine – EP PerMed”
18 February 2021 – ICPerMed and ERA PerMed published a jointly developed draft concept paper for the candidate European Partnership for Personalised Medicine – EP PerMed.
-
ICPerMed Conference 2021: Virtual platform is now open!
01 February 2021 – The virtual platform for the ICPerMed conference 2021 “Personalised Medicine – from Vision to Practice” is now open. The conference will take place virtually on February 25-26. During two half-days, ICPerMed will discuss and promote solutions and strategies on how to implement successfully personalised medicine approaches.
-
PerMedCoE: Exascale-ready cell-level simulations
21 January 2021 – Coordinated by the Barcelona Supercomputing Center (BSC) and funded by the European Commission, this recently launched high-performance computing (HPC) centre of excellence will optimise codes for cell-level simulations and bridge the gap between organ and molecular simulations, thus contributing to the European Personalised Medicine Roadmap.
-
CSA STARS – Strengthening Training of Academia in Regulatory Science
20 January 2021 – This coordination and support action funded by the EU aims to improve the direct regulatory impact of results obtained in medical research. More information about their current activities can be found in their recently published newsletter.
-
HEcoPerMed published the 1st Newsletter
19. January 2021 – CSA HEcoPerMed stands for “Healthcare- and pharmaeconomics in support of the International Consortium for Personalised Medicine – ICPerMed”
-
ERA PerMed Information Event JTC2021
11. January 2021 – ERA PerMed will organize an Information Event for potential applicants for the Joint Transnational Call 2021 “MULTIDISCIPLINARY RESEARCH PROJECTS ON PERSONALISED MEDICINE – DEVELOPMENT OF CLINICAL SUPPORT TOOLS FOR PERSONALISED MEDICINE IMPLEMENTATION”. The meeting will take place online on the 25th of January 2021, 13:00 to 14:30 (CET).
